# The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer

> **NCT01852838** · — · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 70 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01852838
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2014-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852838, "The Contribution of Induced Glycolysis to the Exhaled Volatile Organic Compounds' (VOCs) Signature in Lung Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01852838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*